Maingene listed on the Hong Kong Stock Exchange: IPO with a market value of HK $4.3 billion was ignored by the market

RedI network Lei Jianping 6 month 26 Reported Wednesday

Mein gene （6667.HK） On 2022 year 6 month 22 Listing in Hong Kong , This sale 1196.18 Ten thousand shares , Issue price 18 The Hong Kong dollar , The total amount raised is 1.53 Million Hong Kong dollars .

As of today , Memgene shares 17.96 The Hong Kong dollar , Basically the same as the issue price ; Calculated at the current closing price , The market value of memgene is 42.97 Million Hong Kong dollars .

The listing of Meiyin gene has not caused much response in the industry , The attention received was average . Mein gene went on the market quietly .

Annual revenue 2.37 Billion

According to introducing ,2006 year , Yu Rong, chairman of meinian health, established Shanghai Tianyi Asset Management Co., Ltd , Make industrial supporting services for meinian .

Yu Rong thought at that time , The great health of the United States should be in prevention 、 The diagnosis 、 Screening and other peripheral new technologies and new projects , A long-term mechanism needs to be established , Among them, those early long cycles are necessary 、 Peripheral cultivation projects , Tianyi group is the incubation platform for these projects .

2016 In, a project with public health gene testing as the core was incubated on Tianyi platform —— Mein gene . In order to strengthen the strategic synergy between Meiyin gene and the company ,2018 year , Meinian health has achieved holding of Meiyin gene .

The prospectus shows , Mein gene 2019 year 、2020 year 、2021 The annual revenue is 1.24 One hundred million yuan 、2.03 One hundred million yuan 、2.37 One hundred million yuan ; The gross profit is 7848 Ten thousand yuan 、1.46 One hundred million yuan 、1.67 One hundred million yuan ; The profits during the period are 2969 Ten thousand yuan 、7910 Ten thousand yuan 、7902 Ten thousand yuan .

Mein gene 2019 year 、2020 year 、2021 The adjusted net profit for the year is 4622 Ten thousand yuan 、9380 Ten thousand yuan 、8514 Ten thousand yuan .

Meinian great health is a shareholder The executive director of Mein gene is Dr. Yu Rong 、 Ms. Lin Lin 、 Huang Yufeng 、 Ms. Jiang Jing ; The non-executive director is Ms. Guo Meiling , The independent non-executive director of memgene is Dr. Zhang Ying 、 Jia Qingfeng 、 Dr. sherdan .

IPO front ,Infinite Galaxy Health Limited The shareholding is 18.63%, It is wholly owned by meinianda health . Dr. Yu serves as the director and chairman of meinian health .Infinite Galaxy Health Limited The shareholding is 11%, It is owned by Ms. Guo Meiling . Yu Rong passed YURONG TECHNOLOGY LIMITED The shareholding is 7.28%.

Tianjin Century Yuneng enterprise management partnership （ Limited partnership ） The shareholding is 6.05%, Tianjin Damei Shengjian enterprise management partnership （ Limited partnership ） The shareholding is 5.52%,Main Mercury Technology Limited holding 5.26%,LINLIN DJK HOLDING LTD.high by 4.99%, Tianjin Hongzhi health management consulting Partnership （ Limited partnership ） The shareholding is 4.12%,Sampure Technology Ltd. The shareholding is 3.2%.

Main Mars Holding holding 3%,Main Splendid Spring Technology holding 2.53%,Maccura Biotechnology (USA) LLC、GRteam Global Their respective shareholdings are 2.47%.

Tianjin fandingjiayin enterprise management partnership （ Limited partnership ）、Main Sunshine Technology Limited Their respective shareholdings are 2%, Tianjin Ruihua enterprise management partnership （ Limited partnership ）、 Tianjin Zhongcai Rongxin Consulting Center （ Limited partnership ） Their respective shareholdings are 1.92%.

———————————————

Lei Di was founded by Lei Jianping, a senior media person , If reproduced, please indicate the source .